Mereo BioPharma Group PLC (MREO)
4.01
-0.27
(-6.31%)
USD |
NASDAQ |
Nov 04, 16:00
4.025
+0.02
(+0.37%)
After-Hours: 20:00
Mereo BioPharma Group Shareholders Equity (Quarterly): 78.65M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 78.65M |
| March 31, 2024 | 42.84M |
| June 30, 2023 | 72.83M |
| December 31, 2022 | 51.40M |
| June 30, 2022 | 84.40M |
| June 30, 2022 | 84.40M |
| December 31, 2021 | 118.77M |
| June 30, 2021 | 111.66M |
| June 30, 2021 | 111.66M |
| December 31, 2020 | -20.40M |
| June 30, 2020 | 29.84M |
| June 30, 2020 | 29.84M |
| December 31, 2019 | 52.78M |
| Date | Value |
|---|---|
| June 30, 2019 | 74.81M |
| June 30, 2019 | 74.81M |
| December 31, 2018 | 41.58M |
| June 30, 2018 | 61.64M |
| June 30, 2018 | 61.64M |
| December 31, 2017 | 84.44M |
| June 30, 2017 | 96.32M |
| June 30, 2017 | 96.32M |
| December 31, 2016 | 97.79M |
| June 30, 2016 | 121.31M |
| June 30, 2016 | 121.31M |
| December 31, 2015 | 52.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-20.40M
Minimum
Dec 2020
118.77M
Maximum
Dec 2021
65.28M
Average
72.83M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| NuCana PLC | 4.806M |
| TC BioPharm (Holdings) PLC | 1.364M |
| Adaptimmune Therapeutics PLC | 96.27M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| Bicycle Therapeutics PLC | 831.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.13M |
| Total Liabilities (Quarterly) | 17.48M |